Welcome to Macroaxis
Sign in to go to your portfolios
Don't have an account? Create It
  Macroaxis: Personalized Investing   The proven technology to invest wisely
Macroaxis Country Selector USA  Change      Macroaxis User Registration Register    Macroaxis User Login Sign In
   



Processing
Collecting data for ACUR

Acura performance

    
    

Acura Pharmaceuticals Inc.

 Stock@American Stock Exchange 
United States
    
Use Acura Pharmaceuticals Inc. performance with your portfolios to protect against small markets fluctuations as well as to determine Stock diversification method that is right for you.
    
    
       
Investment horizon: 
30 Days (Login to change)
       

Relative Risk vs. Return Landscape

If you would invest 325.00 in Acura Pharmaceuticals Inc. on April 25, 2012 and sell it today you would lose (37.00) from holding Acura Pharmaceuticals Inc. or give up 11.38% of portfolio value over 30 days. Acura Pharmaceuticals Inc. is currenly does not generate positive expected returns and assumes 2.95% risk (volatility on return distribution) over the 30 days horizon. In different words, 49% of equities are less volatile than Acura Pharmaceuticals Inc. and 99% of traded equity instruments are projected to make higher returns than the company over the 30 days investment horizon.
Daily Expected Return (%)
Risk [Daily Volatility] (%)
Given investment horizon of 30 days, Acura Pharmaceuticals Inc. is expected to under-perform the market. In addition to that, the company is 3.88 times more volatile than its market benchmark. It trades about -0.18 of its total potential returns per unit of risk. The NYSE is currently generating roughly -0.39 per unit of volatility.

Acura Operating Margin

Based on recorded statements Acura Pharmaceuticals Inc. has Operating Margin of 54%. This is 307.98% lower than that of Healthcare sector, and 199.09% lower than that of Drug Delivery industry, The Operating Margin for all stocks is 1203.04% lower than the firm.
A good Operating Margin is required for a company to be able to pay for its fixed costs or pay out its debt which implies that the higher the margin, the better. This ratio is most effective in evaluating the earning potential of a company over time when comparing it against firm's competitors.

Discuss Acura performance

       
       
    
Acura
Performance
0
Out Of
100
Over 30
Days
Over the last 30 days Acura Pharmaceuticals Inc. has generated negative risk-adjusted returns adding no value to investors with long positions.
    

1 Month Effecincy (a.k Sharpe Ratio) ...

-0.18
Best
Portfolio
Best
Equity
Good Returns
Average Returns
Small Returns
CashSmall
Risk
Average
Risk
High
Risk
Huge
Risk
Negative ReturnsACUR

Estimated Market Risk

 2.95
  actual daily
 
 51 %
of total potential
 
Market Risk score

Expected Return

 -0.52
  actual daily
 
 1 %
of total potential
 
Expected Return score

Risk-Adjusted Return

 -0.18
  actual daily
 
 1 %
of total potential
 
Risk-Adjusted Return score
Based on monthly moving average Acura is performing at about 0% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Acura by adding it to a well-diversified portfolio.
    
Follow Acura Performance with your standard RSS feed, custom widget, or your favorite social app
Add To Reader
 
Add Acura to your reader
 
Get social with Acura Performance
 Acura Performance 
Share Toggle social options for Acura Performance
    



 

 
Analytics
Investor Landscape
Efficient Frontier
Market Correlation
Risk and Return Analysis
Financial Content
Portfolio Projections
Portfolio Backtesting
Tools
FAQs
Retirement Optimizer
RSS and Mobile Access
Company Directory
Advisor Directory
Insider Directory
Wealth Management
About Us
About Macroaxis
Contact Us
Terms Of Use
Privacy Policy
Custom Reporting
Product Tour
More ROI Custom Reporting